Your browser is no longer supported. Please, upgrade your browser.
PFE Pfizer Inc. daily Stock Chart
Pfizer Inc.
IndexDJIA S&P500 P/E18.27 EPS (ttm)2.40 Insider Own0.10% Shs Outstand5.94B Perf Week-0.27%
Market Cap260.17B Forward P/E14.28 EPS next Y3.07 Insider Trans-11.61% Shs Float5.80B Perf Month0.64%
Income14.41B PEG2.46 EPS next Q0.64 Inst Own74.20% Short Float0.82% Perf Quarter1.96%
Sales53.37B P/S4.87 EPS this Y68.20% Inst Trans0.42% Short Ratio2.04 Perf Half Y20.46%
Book/sh12.14 P/B3.61 EPS next Y2.06% ROA14.20% Target Price44.15 Perf Year19.54%
Cash/sh2.90 P/C15.09 EPS next 5Y7.42% ROE33.70% 52W Range33.20 - 46.47 Perf YTD20.93%
Dividend1.36 P/FCF26.59 EPS past 5Y10.40% ROI11.00% 52W High-5.75% Beta0.90
Dividend %3.11% Quick Ratio1.20 Sales past 5Y-0.80% Gross Margin79.10% 52W Low31.93% ATR1.02
Employees90200 Current Ratio1.40 Sales Q/Q1.00% Oper. Margin26.40% RSI (14)46.70 Volatility2.07% 2.20%
OptionableYes Debt/Eq0.58 EPS Q/Q45.80% Profit Margin44.60% Rel Volume1.28 Prev Close44.57
ShortableYes LT Debt/Eq0.47 EarningsOct 30 BMO Payout33.40% Avg Volume23.16M Price43.80
Recom2.70 SMA20-0.99% SMA50-0.48% SMA20010.80% Volume29,626,602 Change-1.73%
Dec-11-18Downgrade JP Morgan Overweight → Neutral
Nov-01-18Downgrade BMO Capital Markets Outperform → Market Perform
Jun-08-18Initiated Cantor Fitzgerald Overweight $45
Apr-05-18Downgrade Barclays Overweight → Equal Weight $41 → $38
Jan-29-18Reiterated SunTrust Hold $33 → $40
Sep-20-17Upgrade Morgan Stanley Equal-Weight → Overweight
Jul-20-17Downgrade Credit Suisse Outperform → Neutral
May-16-17Downgrade Citigroup Neutral → Sell
Dec-02-16Initiated Guggenheim Neutral
Nov-02-16Downgrade Argus Buy → Hold
Oct-13-16Downgrade Jefferies Buy → Hold
Jun-20-16Reiterated Jefferies Buy $42 → $40
May-12-16Initiated Berenberg Hold $38
May-04-16Reiterated UBS Buy $36 → $38
Apr-18-16Resumed Goldman Neutral $35
Apr-07-16Resumed Morgan Stanley Equal-Weight $35
Apr-07-16Resumed JP Morgan Overweight $38
Nov-25-15Upgrade Sun Trust Rbsn Humphrey Reduce → Neutral
Nov-03-15Reiterated Argus Buy $41 → $46
Oct-28-15Reiterated Deutsche Bank Buy $41 → $43
Dec-14-18 01:39PM  Pfizer Boosts Q1 Dividend, Launches $10 Billion Buyback as Read Says Farewell
12:26PM  Pfizer's cut-price version of Avastin wins EU panel greenlight Reuters
12:10PM  Pfizer Declares First-Quarter 2019 Dividend Business Wire
10:29AM  Pfizer Receives Positive CHMP Opinion for Oncology Biosimilar, ZIRABEV (bevacizumab) Business Wire
09:28AM  Should You Invest in the VanEck Vectors Pharmaceutical ETF (PPH)? Zacks
08:41AM  Merck bolsters animal health unit with $2.4 bln Antelliq purchase Reuters
08:19AM  Pharma Stock Roundup: AZN, RHHBY Cancer Drugs, LLY, BMY New Deals in Focus Zacks
08:00AM  Pfizer Initiates Phase 3 Program for 20-Valent Pneumococcal Conjugate Vaccine for the Prevention of Invasive Disease and Pneumonia in Adults Aged 18 Years and Older Business Wire
07:05AM  Today's Research Reports on Trending Tickers: Pfizer and Merck & Co. ACCESSWIRE
Dec-13-18 09:27AM  Is Franklin LibertyQ U.S. Equity ETF (FLQL) a Strong ETF Right Now? Zacks
09:06AM  Are You Overlooking This High-Growth Industry During Corrections and Recessions? Motley Fool
Dec-12-18 08:59AM  5 Bargain Dividend Stocks to Buy Now Kiplinger
08:52AM  Pfizer's (PFE) Shares Drop on Rating Downgrade by JP Morgan Zacks
08:18AM  3 Stocks That Could Help You Send Your Kids to College Motley Fool
07:20AM  Report: Developing Opportunities within Pfizer, Bed Bath & Beyond, Vishay Intertechnology, Cloudera, Markel, and QTS Realty Trust Future Expectations, Projections Moving into 2018 GlobeNewswire
Dec-11-18 04:13PM  Stocks End Mixed as China Trade Progress Offsets D.C. Dysfunction
11:57AM  US STOCKS-Tech stocks buoy Wall St as China-U.S. trade talk progress Reuters
11:18AM  Pfizer Slips After JPMorgan Downgrade on Patent Cycle Concerns
09:12AM  US STOCKS-Wall Street set to jump at open on trade talk progress Reuters
08:43AM  Stocks - U.S. Futures Lifted on News of Trade Talks
08:18AM  Pfizer shares fall premarket after JPMorgan downgrades to neutral MarketWatch
07:57AM  Stocks making the biggest moves premarket: DSW, F, GM, CVS, PFE & more CNBC
07:49AM  US STOCKS-Futures rise 1 pct on China-U.S. trade talk progress Reuters
07:31AM  JP Morgan downgrades Pfizer, saying stock has moved too far, too fast: 'Moving to the sidelines' CNBC
07:18AM  [$$] Stocks to watch: WPP, 888, Pfizer, Aviva, Standard Life, BASF, Total Financial Times
Dec-10-18 05:45PM  Pfizer (PFE) Outpaces Stock Market Gains: What You Should Know Zacks
11:30AM  Generic drug makers stocks fall sharply after report of expanded price-fixing probe MarketWatch
10:11AM  PFE Stock Has Broken Its Slump and Could Challenge Former Highs InvestorPlace
09:45AM  ATRS: Xyosted & Epi Pen Available for Sale Zacks Small Cap Research
Dec-09-18 06:30PM  Stock Market Power Rankings: Amazon Takes Control Motley Fool
Dec-08-18 07:41PM  Is Pfizer Inc. (PFE) A Good Stock To Buy According To Hedge Funds? Insider Monkey
Dec-06-18 05:11PM  Peninsula drug maker to pay $360M to settle Justice Department claims American City Business Journals
02:51PM  Conatus' Emricasan Misses Primary Endpoint in Mid-Stage Study Zacks
01:26PM  Pfizer Falls 3%
09:10AM  Exelixis Initiates Pivotal Liver Cancer Study on Cabometyx Zacks
06:59AM  Four stocks have avoided the market crush to hit new highs CNBC
04:15AM  China's Drugmakers Plunge Most Since 2009 on Price Concerns Bloomberg
Dec-05-18 07:00AM  Today's Research Reports on Trending Tickers: Pfizer and Merck & Co. ACCESSWIRE
Dec-04-18 05:45PM  Pfizer (PFE) Stock Moves -1.78%: What You Should Know Zacks
06:19AM  [$$] CEOs question the bite behind the bark of Trumps tweets Financial Times
06:00AM  3 Big Pharma Stocks Hitting 52-Week Highs -- Are They Buys? Motley Fool
Dec-03-18 11:15AM  DARE: Ovaprene PCT Continues. TS Content Validity Study, Thermographic Study Underway Zacks Small Cap Research
09:55AM  AbbVie Settles With Pfizer for Humira Biosimilar in U.S. Zacks
09:08AM  Mondays Vital Data: Pfizer, Goldman Sachs and Caterpillar InvestorPlace
Dec-02-18 03:45PM  Pfizer Presents Positive 26-Week Data For PF-05280586, A Potential Biosimilar To Rituximab, At The American Society Of Hematology Annual Meeting Business Wire
Nov-30-18 07:04PM  Delayed Humira Biosimilar Boosts AbbVie's Fair Value Morningstar
05:24PM  U.S. Stocks Sprint Ahead to End a Blockbuster Week
04:29PM  Stock Market Stages Bullish Reversal To Cap Week With Big Gains Investor's Business Daily
04:16PM  Pfizer Stock Edges Into Buy Zone On AbbVie Deal For Humira Biosimilar Investor's Business Daily
02:17PM  Pfizer Is in Breakout-Mode This Fall: Chart
01:16PM  Bulls shop for TJX. Plus, the trade on Pfizer CNBC Videos
10:00AM  Pfizer Reaches a Global Agreement with AbbVie Business Wire
07:23AM  Dow 30 Stock Roundup: BA's $383M Modification Contract, MSFT's Army Contract Zacks
Nov-29-18 05:30PM  Why Pfizer Could Lead These Two Biotech Stocks In Tackling Amyloidosis Investor's Business Daily
01:39PM  Bayer To Cut 12,000 Jobs Amid Strategic Overhaul To Focus On Pharma Investor's Business Daily
11:56AM  Bayer to sell businesses, cut jobs after Monsanto deal Reuters
09:31AM  Pfizer (PFE) Up 4.3% Since Last Earnings Report: Can It Continue? Zacks
08:38AM  Roche (RHHBY) to Acquire Jecure and Enter the NASH Space Zacks
08:10AM  4 Big Pharma Stocks to Add to Your Portfolio in December Zacks
Nov-28-18 06:36PM  Merck raised prices five drugs including Keytruda in November Reuters
05:45PM  Pfizer (PFE) Gains But Lags Market: What You Should Know Zacks
05:19PM  Galapagos' Osteoarthritis Candidate Gets Fast Track Status Zacks
05:09PM  Pfizer's Epilepsy Drug Lyrica Gets Pediatric Exclusivity Zacks
10:22AM  Aileron Inks Collaboration Deal With Pfizer for Cancer Combo Zacks
Nov-27-18 03:01PM  Pfizer Receives Six Months Pediatric Exclusivity for LYRICA® (pregabalin) Business Wire
01:41PM  Roche buys U.S. biotech Jecure in race for liver disease drugs Reuters
09:40AM  Glaxo (GSK) and J&J's HIV Drug Juluca Gets Approval in Japan Zacks
07:44AM  The Zacks Analyst Blog Highlights: Boeing, Microsoft, Johnson & Johnson, Chevron and Pfizer Zacks
Nov-26-18 05:28PM  Google asks for refund of campaign contribution to embattled Sen. Cindy Hyde-Smith CNBC
03:16PM  Spark Therapeutics' Luxturna Gets EU Approval for Vision Loss Zacks
11:33AM  Bayer looks at options for consumer brands, animal health - sources Reuters
10:45AM  ATRS: Xyosted Launch Before Year End Zacks Small Cap Research
10:22AM  Bayer discusses sale of some consumer brands, future of animal health-sources Reuters
09:23AM  The Zacks Analyst Blog Highlights: Pfizer, AbbVie, J&J, Glaxo and AstraZeneca Zacks
Nov-25-18 11:30AM  Better Buy: Pfizer vs. Bristol-Myers Squibb Motley Fool
Nov-23-18 06:56PM  [$$] Pharma Stocks Soothe Stock-Market Malady The Wall Street Journal
11:17AM  These 3 Stocks Are Up 25% in 2018 -- Are They Still Buys? Motley Fool
08:58AM  Pharma Stock Roundup: Cancer Approvals for PFE & ABBV, CHMP Nod for Several Drugs Zacks
08:10AM  Dow 30 Stock Roundup: Boeing to Supply 40 737 MAX 8 to Jeju Air, Pfizer Gets FDA Nod Zacks
Nov-22-18 09:16AM  Pfizer's FDA Nod for Cancer Drug is Four in a Row in 90 Days Zacks
Nov-21-18 02:17PM  FDA approves new blood cancer treatment from Pfizer Reuters
02:17PM  Pfizer Stock Has Multiple Positive Catalysts InvestorPlace
02:02PM  Pfizer asks GOP Sen. Cindy Hyde-Smith for contribution refund, Facebook alum Sean Parker doesn't CNBC
01:40PM  U.S. FDA Approves DAURISMO (glasdegib) for Adult Patients with Newly-Diagnosed Acute Myeloid Leukemia (AML) for Whom Intensive Chemotherapy is Not an Option Business Wire
01:10PM  FDA approves Pfizer's treatment for rare blood cancer Reuters
10:00AM  Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference Business Wire
09:44AM  FDA Accepts Allergan's (AGN) sNDA for Anti-Infective Avycaz Zacks
06:00AM  5 Quality Blue Chips to Thrive in Bull and Bear Markets Investopedia
02:08AM  [$$] Global markets retreat as tech rout spreads Financial Times
Nov-20-18 04:24PM  Corcept Initiates Phase III Study for Cushing's Syndrome Zacks
03:30PM  [$$] Diversis Capital Buys Controlling Stake of Tempo The Wall Street Journal
08:12AM  Pfizer's Bavencio Phase III Study for Ovarian Cancer Fails Zacks
06:00AM  Pfizer and 3 Other Stock Picks From a 5-Star Growth Fund
Nov-19-18 06:08PM  Stock Market Today: Sea of Red Investopedia
05:45PM  Pfizer (PFE) Gains As Market Dips: What You Should Know Zacks
05:15PM  Nasdaq Slides More Than 3% As These Dow Blue Chips Buck The Broad Sell-Off Investor's Business Daily
05:08PM  Pfizer Shares Jump on Monday After Company Signals Higher Price Push
04:29PM  Pfizer to raise drug prices despite Trumps complaints Fox Business Videos
04:23PM  Tech Selloff Could Work in Favor of Pharmaceutical Stocks
04:21PM  Pfizer's Ovarian Cancer Treatment Fails In Late-Stage Test Investor's Business Daily
Pfizer Inc. discovers, develops, manufactures, and sells healthcare products worldwide. It operates in two segments, Pfizer Innovative Health (IH) and Pfizer Essential Health (EH). The IH segment focuses on the development and commercialization of medicines and vaccines, and consumer healthcare products in various therapeutic areas, including internal medicine, vaccines, oncology, inflammation and immunology, and rare diseases, as well as consumer healthcare, such as over-the-counter brands comprising dietary supplements, pain management, gastrointestinal, and respiratory and personal care. This segment offers products primarily under the Prevnar 13/Prevenar 13, Xeljanz, Eliquis, Lyrica, Enbrel, Ibrance, Xtandi, Advil, and Centrum brands. The EH segment offers products that would lose or have lost marketing patent protection; branded generic products; generic sterile injectable products; biosimilars; and anti-infectives. It provides products under the Lipitor, Premarin family, Norvasc, Lyrica, Celebrex, Viagra, Inflectra/Remsima, Pristiq, Zyvox, Vfend, Revatio, Inspra, Medrol, Sulperazon, Fragmin, Tygacil, Nivestim, and Retacrit brands. This segment also engages in the research and development, as well as contract manufacturing activities. The company serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. Pfizer Inc. has collaboration and/or co-promotion agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; Immutep Limited; BioNTech AG; Neofluidics, LLC; Kite Pharma, Inc.; Merck KGaA; Leap Therapeutics, Inc.; and Nektar Therapeutics, as well as development agreement with Antares Pharma, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
READ IAN CChairman & CEONov 02Option Exercise26.641,100,20129,312,5881,760,958Nov 06 03:46 PM
PFIZER INC10% OwnerOct 15Buy18.0055,5561,000,00822,032,040Oct 17 05:17 PM
Dolsten MikaelPresident R&DSep 13Option Exercise24.56181,7124,462,167234,299Sep 17 04:08 PM
OLSON LAURIE JExecutive Vice PresidentAug 13Sale41.0010,214418,77472,672Aug 14 05:04 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentAug 03Sale39.5125,6421,013,171102,412Aug 06 03:19 PM
GOETTLER MICHAELGroup PresidentAug 01Sale39.7019,198762,11611,924Aug 03 03:38 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerAug 01Sale40.1626,8141,076,93383,846Aug 03 03:36 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentAug 01Sale40.0420,942838,5724,643Aug 03 03:35 PM
DAMELIO FRANK AExecutive Vice PresidentAug 01Sale40.00150,4846,019,360337,391Aug 03 03:33 PM
SUSMAN SALLYExecutive Vice PresidentJul 20Sale37.2240,3811,502,925115,096Jul 24 01:09 PM
READ IAN CChairman & CEOJul 16Sale37.36486,75318,186,315659,440Jul 17 04:59 PM
OLSON LAURIE JExecutive Vice PresidentJun 06Sale36.4519,000692,58282,886Jun 08 01:11 PM
CORNWELL W DONDirectorJun 04Sale36.405,223190,1170Jun 05 04:44 PM
READ IAN CChairman & CEOMay 01Sale36.01132,3124,764,0811,144,703May 03 04:19 PM
JOHNSON RADY AExecutive Vice PresidentMar 13Sale36.5527,323998,66643,178Mar 14 05:19 PM
LANKLER DOUGLAS MExecutive Vice PresidentMar 13Sale36.8950,0001,844,39883,857Mar 14 05:13 PM
Dolsten MikaelPresident R&DMar 09Sale36.5969,6992,550,39451,185Mar 12 05:01 PM
HILL CHARLES HExecutive Vice PresidentMar 06Sale35.7642,3931,515,98557,328Mar 07 04:09 PM
Dolsten MikaelPresident R&DMar 02Sale35.8513,986501,398120,884Mar 05 09:23 AM
HILL CHARLES HExecutive Vice PresidentFeb 28Option Exercise27.37101,8722,788,237207,942Mar 02 03:24 PM
YOUNG JOHN DGroup PresidentFeb 28Option Exercise27.37121,1453,315,739362,707Mar 02 04:10 PM
OLSON LAURIE JExecutive Vice PresidentFeb 28Option Exercise27.3738,5461,055,004132,702Mar 02 04:02 PM
READ IAN CChairman & CEOFeb 28Option Exercise27.37649,78017,784,4791,774,184Mar 02 04:03 PM
SUSMAN SALLYExecutive Vice PresidentFeb 28Option Exercise27.37110,1323,014,313245,362Mar 02 04:03 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentFeb 28Option Exercise27.3719,273527,50239,801Mar 02 03:44 PM
JOHNSON RADY AExecutive Vice PresidentFeb 28Option Exercise27.3719,273527,50285,910Mar 02 03:44 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 28Option Exercise27.3746,8061,281,080171,276Mar 02 03:44 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 28Option Exercise27.37104,6262,863,614384,219Mar 02 03:44 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 28Option Exercise27.37209,2515,727,200655,161Mar 02 03:24 PM
BOURLA ALBERTChief Operating OfficerFeb 28Option Exercise27.3739,9231,092,693184,120Mar 02 03:24 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 28Option Exercise27.3733,040904,305136,847Mar 02 03:24 PM
Dolsten MikaelPresident R&DFeb 28Option Exercise27.37198,2385,425,774293,352Mar 02 03:24 PM
HILL CHARLES HExecutive Vice PresidentFeb 28Sale36.8326,779986,292181,163Mar 02 03:24 PM
SUSMAN SALLYExecutive Vice PresidentFeb 27Sale37.0333,3681,235,591135,230Feb 28 06:14 PM
Dolsten MikaelPresident R&DFeb 27Sale37.0464,5872,392,31395,114Feb 28 06:04 PM
CORNWELL W DONDirectorFeb 27Sale37.0530011,1150Feb 28 01:29 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentFeb 26Sale37.199,510353,67717,770Feb 27 07:38 PM
CORNWELL W DONDirectorFeb 26Sale36.741,45853,5640Feb 28 01:29 PM
YOUNG JOHN DGroup PresidentFeb 24Option Exercise18.9043,520822,528223,733Feb 27 08:59 PM
READ IAN CChairman & CEOFeb 24Option Exercise19.83903,55917,917,2651,560,007Feb 27 08:58 PM
OLSON LAURIE JExecutive Vice PresidentFeb 24Option Exercise18.9015,716297,03290,222Feb 27 07:53 PM
SUSMAN SALLYExecutive Vice PresidentFeb 24Option Exercise18.9091,8761,736,456206,972Feb 27 07:51 PM
JOHNSON RADY AExecutive Vice PresidentFeb 24Option Exercise18.9015,885300,22762,848Feb 27 07:43 PM
LANKLER DOUGLAS MExecutive Vice PresidentFeb 24Option Exercise18.9028,288534,643112,081Feb 27 07:43 PM
Lewis-Hall Freda CExecutive Vice PresidentFeb 24Option Exercise18.9091,8761,736,456313,499Feb 27 07:43 PM
LUND-JURGENSEN KIRSTENExecutive Vice PresidentFeb 24Option Exercise18.9015,957301,58736,959Feb 27 07:38 PM
MACKENZIE ALEXANDER RExecutive Vice PresidentFeb 24Option Exercise18.9039,555747,590143,152Feb 27 07:38 PM
HILL CHARLES HExecutive Vice PresidentFeb 24Option Exercise18.9065,2801,233,792122,609Feb 27 07:38 PM
Dolsten MikaelPresident R&DFeb 24Option Exercise18.90174,0813,290,131225,265Feb 27 07:32 PM
CANGIALOSI LORETTA VSr. Vice President, ControllerFeb 24Option Exercise18.9028,288534,643116,769Feb 27 07:30 PM
BOURLA ALBERTChief Operating OfficerFeb 24Option Exercise18.9025,387479,814158,170Feb 27 07:30 PM
DAMELIO FRANK AExecutive Vice PresidentFeb 24Option Exercise18.90174,0813,290,131511,470Feb 27 07:30 PM